CASE DISCUSSION

Gestational Diabetes Mellitus

Presented from India by Dr. Dina Nagodra Mithani

Likes

187000

Views

7,480

5,610

Bookmarks

Case Description

Gestational Diabetes Mellitus (GDM) is a condition characterized by elevated blood sugar levels during pregnancy, typically developing in the second or third trimester. It arises when the body cannot produce enough insulin to meet the increased demands of pregnancy, leading to insulin resistance....

Case Summary

Gestational diabetes mellitus (GDM) is a condition where placental hormones block insulin's effectiveness, leading to high blood glucose. This isn't due to insulin deficiency but rather insulin resistance caused by hormones like estrogen, cortisol, and placental lactogen, typically starting around 20-24 weeks of pregnancy. While symptoms usually disappear post-delivery, GDM can affect up to 25% of pregnancies worldwide.

Speaker Profile

Dr. Dina Nagodra Mithani

Endocrinologist, DENMARC Institute, Mumbai

Dr. Dina Nagodra Mithani is a highly qualified and experienced diabetes and endocrinology specialist with a comprehensive educational background and extensive international work experience. She holds postgraduate diplomas in endocrinology and diabetes from the University of South Wales, the International Diabetes Federation, the Royal College of Physicians, and Fortis CDOC, as well as a postgraduate certificate in stem cell and regenerative medicine from the University of Utrecht. Additionally, she has a Master of Science in Public and Tropical Health and was promoted for a PhD at the University of Medical Sciences and Technology in Sudan, where she also earned her Bachelor of Science in Medicine and Surgery. Dr. Mithani's career spans several countries, including roles at the DENMARC Institute in Mumbai, the Omdurman Military Hospital in Sudan, the Norfolk and Norwich University Hospital in the UK, and the Midland Regional Hospital in Ireland. She has provided diabetes and endocrinology services in various clinical settings, such as the Acute Medical Assessment Unit at Wexford General Hospital and the Abdalla Khalil Diabetes Center in Sudan. Her experience also includes working in intensive care at Imperial Private Hospital and serving with the State Ministry of Health in Khartoum. In addition to her clinical work, Dr. Mithani has contributed significantly to medical research, with publications in esteemed journals like the New England Journal of Medicine. Her research topics include diabetes in pregnancy, the relationship between diabetes and heart failure, diabetic neuropathy, cardiometabolic disease, and novel therapies for diabetes management. Dr. Mithani's dedication to her field is reflected in her ongoing efforts to improve diabetes care and outcomes for patients globally.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.